|
Orenes-Piñero E, Pineda J, Roldán V, Hernández-Romero D, Marco P, Tello-Montoliu A, Sogorb F, Valdés M, Lip GY, Marín F. Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State. J Atheroscler Thromb. 2015;22(6):610-7. doi: 10.5551/jat.26161. PubMed PMID: 25737193.
AÑO: 2015; IF: 2.411
|
25737193
|
Darlington A, Tello-Montoliu A, Rollini F, Ueno M, Ferreiro JL, Patel R, Desai B, Guzman LA, Bass TA, Angiolillo DJ. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Thromb Haemost. 2014 Feb;111(2):258-65. doi: 10.1160/TH13-07-0529. PubMed PMID: 24154863.
AÑO: 2014; IF: 4.984
|
|
Rollini F, Tello-Montoliu A, Patel R, Darlington A, Wilson RE, Franchi F, Muñiz-Lozano A, Desai B, Bender N, Sakariassen KS, Angiolillo DJ. Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation. J Thromb Thrombolysis. 2014 Apr;37(3):358. doi: 10.1007/s11239-013-1003-z. PubMed PMID: 24101257.
AÑO: 2014; IF: 2.169
|
|
Rollini F, Tello-Montoliu A, Patel R, Darlington A, Wilson RE, Franchi F, Muñiz-Lozano A, Desai B, Bender N, Sakariassen KS, Angiolillo DJ. Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation. J Thromb Thrombolysis. 2014;37(2):131-8. doi: 10.1007/s11239-013-0979-8. PubMed PMID: 23943337.
AÑO: 2014; IF: 2.169
|
|
Ferreiro JL, Ueno M, Tello-Montoliu A, Tomasello SD, Seecheran N, Desai B, Rollini F, Guzman LA, Bass TA, Angiolillo DJ. Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy. JACC Cardiovasc Interv. 2013 Feb;6(2):182-4. doi: 10.1016/j.jcin.2012.10.007. PubMed PMID: 23428011.
AÑO: 2013; IF: 3.534
|